|
|
Article: Verdezyne Receives Federal Grant to Advance Synthetic Biology Tools.
- Article from:
- Engineering Business Journal
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Verdezyne, Inc., a privately-held synthetic biology company developing fermentation processes for industrial chemicals and biofuels, announced that they have been awarded a $1.7 million grant from the National Institute of Allergy And Infectious Diseases (NIAID) for a period of 1.5 years. The goal of this program is to quickly and reliably advance the construction of directed mutant gene libraries widely considered important technology tools for synthetic biology.
Verdezyne will apply their proprietary computational and bioinformatics programs to create highly diverse gene libraries to further enhance metabolic engineering tools. This enhanced capability will be ...
Related newspaper, magazine, and journal articles:
|
|
Article: NIAID PLAN OFFERS INCENTIVES FOR WORK TO FIGHT ...
BIOWORLD Today;
December 10, 2001 ;
700+ words
... ... the division of microbiology and infectious diseases at the National Institute of Allergy and Infectious Diseases (NIAID). "A lot of people ... and Vector Control Strategies in Infectious Diseases is for work on new drug development ...
|
|